Analyst
Goldman Sachs
Equibles does not estimate personal net worth.
Sham Shrinivasan is recorded as Analyst at Goldman Sachs. Sham Shrinivasan has spoken on 1 earnings call across 1 company, most recently for Cohance Lifesciences Limited on November 6, 2026. The companies whose calls Sham Shrinivasan spoke on are classified in the Healthcare sector.
“I'm on the road, so just bear with the noise. So, first question is on these three contracts that we have won with BigSama.”
Goldman Sachs
Analyst
Transcript header (unverified)
Cohance Lifesciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended September 30, 2026
Cohance Lifesciences Limited
